As infectious disease epidemiologists and public health scientists we have grave concerns about the damaging physical and mental health impacts of the prevailing COVID-19 policies, and recommend an approach we call Focused Protection
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as…
Show Healthcare Unfiltered, Ep The ABIM-MOC Saga Continues – Apr 16, 2024
Dr. Grace Cordovano, a distinguished Board Certified Patient Advocate and the visionary founder of Enlightening Results, as well as the co-Founder of Unblock…
Show Healthcare Unfiltered, Ep Advocating for Patients in the Contemporary Era With Grace Cordovano – Apr 9, 2024
I am joined today by Simon Arkell, Co-Founder and CEO of Ryght, a pioneering company in the healthcare ecosystem that specializes in producing generative AI…
Show Healthcare Unfiltered, Ep CRISPR for Sickle Cell Disease With James LaBelle – Mar 5, 2024
Show Healthcare Unfiltered, Ep Generative AI With Simon Arkell – Apr 2, 2024
